MDMA AND PSILOCYBIN FOR MENTAL HEALTH: DECONSTRUCTING THE CONTROLLED SUBSTANCES ACT'S USAGE OF "CURRENTLY ACCEPTED MEDICAL USE".
›
Linked as:Extract
MDMA AND PSILOCYBIN FOR MENTAL HEALTH: DECONSTRUCTING THE CONTROLLED SUBSTANCES ACT'S USAGE OF "CURRENTLY ACCEPTED MEDICAL USE".
No longer available (Autolink)
See the full content of this document
This document cites
- Single Convention on Narcotic Drugs, 1961
- Commission Implementing Decision (EU) 2021/7 of 5 January 2021 concerning the extension of the action taken by the Finnish Safety and Chemicals Agency permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 7) (Only the Finnish and Swedish texts are authentic)
- Federal Cases - Bostock v. Clayton Cnty.
- Federal Cases - Gonzales v. Raich
- Federal Cases - General Electric Company v. Gilbert Gilbert v. General Electric Company 19 20, 1976
